跳至主要内容
临床试验/NCT03060473
NCT03060473终止3 期

TREAT: Treatment of ppROM With Erythromycin vs. Azithromycin Trial

The University of Texas Medical Branch, Galveston3 个研究点 分布在 1 个国家目标入组 21 人开始时间: 2017年2月23日最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
终止
入组人数
21
试验地点
3
主要终点
Proportion of Women Still Pregnant by Day 7

研究概览

简要总结

Preterm premature rupture of membranes (PPROM) complicates 4% of pregnancies annually. This pregnancy complication is a major contributor to preterm births and results in neonatal morbidity and mortality. The current standard of care for PPROM subjects between the gestational age of 24 weeks and 0 days and 33 weeks and 6 days, is to administer ampicillin and erythromycin for a total of 7 days. Erythromycin can cause GI upset and some subjects do not tolerate this regimen over the course of 7 days. In addition, there is a national shortage of erythromycin, and published expert opinion proposed to use a second-generation macrolide (azithromycin) instead of erythromycin. Azithromycin can be taken once daily, is cheaper than erythromycin and has less GI upset adverse effects. The investigators' objective is to compare the effectiveness of the 2 regimens in prolonging pregnancy after PPROM. The investigators' working hypothesis is that there is no measurable difference in the primary outcome between the group randomized to the azithromycin regimen versus the group randomized to the erythromycin regimen.

详细描述

In the United States, preterm premature rupture of membranes (PPROM) complicates 4% of pregnancies annually. This pregnancy complication is a major contributor to preterm births and results in neonatal morbidity and mortality. Without treatment, 70-80% of women deliver within the 1st week following membrane rupture. Multiple trials have proven that antibiotics given to this population prolong the latency from time of PPROM to delivery, hence reducing maternal and neonatal morbidities.

According to the American College of Obstetrics and Gynecology, the current standard of care for PPROM subjects between the gestational age of 24 weeks and 0 days and 33 weeks and 6 days, is to administer ampicillin 2 gm IV every 6 hours for 48 hours followed by amoxicillin 250 mg orally every 8 hours for 5 days, with erythromycin 250 mg IV every 6 hours for 48 hours followed by 500 mg orally every 8 hours for 5 days. In this regimen, multiple doses of intravenous (IV) and oral (PO) doses of erythromycin are needed to achieve the desired outcome. Erythromycin can cause GI upset and some subjects do not tolerate this regimen over the course of 7 days. In addition, there is a national shortage of erythromycin, and published expert opinion proposed to use a second-generation macrolide (azithromycin) instead of erythromycin. This strategy was adopted nationwide including the maternal center at UTMB since 2014. Compared to erythromycin, advantages of azithromycin include:

  • It is taken once orally (due to its long intracellular half-life).
  • The entire regimen is much cheaper than the multiple does of erythromycin (23 doses).
  • It has less gastrointestinal adverse effects.

As a result, azithromycin is now commonly being used as a substitute for erythromycin on many labor and delivery units around the country.

Despite its common use, there exists no level 1 evidence that azithromycin is equivalent to erythromycin. Haas and colleagues published a retrospective comparison of the two regimens in 2014 and concluded that the substitution of azithromycin for erythromycin in the recommended antibiotic regimen did not impact latency or any other measured maternal or fetal outcomes. This study, however, was limited by its non-randomized retrospective nature.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

盲法说明

Single Blind

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Maternal age ≥ 18 years and <50 years
  • Pregnant women between the gestational age 23 6/7 and 32 6/7 weeks
  • Singleton pregnancy
  • Preterm premature rupture of membranes, determined clinically
  • Cervical dilation visually ≤ 5cm on sterile speculum exam.
  • Planned delivery at John Sealy Hospital (JSH)

排除标准

  • Intrauterine fetal demise (no fetal heart beat identified and documented by two physicians)
  • Any contraindication to expectant management (e.g. fetal compromise, chorioamnionitis, placental abruption)
  • Cervical cerclage in place
  • Placenta previa or other known placental anomalies
  • Contraindication to any of the antibiotics used (allergy to macrolides).
  • Enrolled in another trial that may affect outcome.
  • Clinical chorioamnionitis or any other active bacterial infection (e.g. pyelonephritis, pneumonia, abscess) at time of randomization: because standard antibiotic therapy for these conditions may confound trial intervention.
  • No prenatal care (less than 2 prenatal visits)
  • Non-resident subject who is unlikely to be followed-up after delivery
  • Any fetal congenital anomaly.
  • Significant liver disease defined as known cirrhosis or elevated transaminases of at least 3-fold upper limit of normal
  • Significant renal disease defined as serum creatinine known to be >2.0 mg/dl or on dialysis.
  • Active congestive heart failure (EF<45%) or pulmonary edema.
  • Immunosuppressed subjects: i.e., taking systemic immunosuppressants or steroids (e.g. transplant subjects; not including steroids for lung maturity), HIV with CD4<200, or other.

研究组 & 干预措施

Azithromycin

Experimental

Ampicillin 2 gm IV every 6 hours followed by amoxicillin 500 mg PO every 8 hours with Azithromycin 1 gm PO once at randomization.

干预措施: Azithromycin (Drug)

Azithromycin

Experimental

Ampicillin 2 gm IV every 6 hours followed by amoxicillin 500 mg PO every 8 hours with Azithromycin 1 gm PO once at randomization.

干预措施: Ampicillin (Drug)

Azithromycin

Experimental

Ampicillin 2 gm IV every 6 hours followed by amoxicillin 500 mg PO every 8 hours with Azithromycin 1 gm PO once at randomization.

干预措施: Amoxicillin (Drug)

Erythromycin

Active Comparator

Ampicillin 2 gm IV every 6 hours followed by amoxicillin 250 mg PO every 8 hours for 5 days with erythromycin 250 mg IV every 6 hours for 48 hours followed by 500 mg PO every 8 hours for 5 days.

干预措施: Erythromycin (Drug)

Erythromycin

Active Comparator

Ampicillin 2 gm IV every 6 hours followed by amoxicillin 250 mg PO every 8 hours for 5 days with erythromycin 250 mg IV every 6 hours for 48 hours followed by 500 mg PO every 8 hours for 5 days.

干预措施: Ampicillin (Drug)

Erythromycin

Active Comparator

Ampicillin 2 gm IV every 6 hours followed by amoxicillin 250 mg PO every 8 hours for 5 days with erythromycin 250 mg IV every 6 hours for 48 hours followed by 500 mg PO every 8 hours for 5 days.

干预措施: Amoxicillin (Drug)

结局指标

主要结局

Proportion of Women Still Pregnant by Day 7

时间窗: 7 days

Proportion of women still pregnant by day 7 after the diagnosis of PPROM is made. The investigators' working hypothesis is that there is no measurable difference in the primary outcome between the group randomized to the azithromycin regimen versus the group randomized to the erythromycin regimen

次要结局

  • Latency Defined as Interval From PPROM to Delivery.(7 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验